- Student Records
Programme & Unit Catalogues


PA50201: Endocrinology

Follow this link for further information on academic years Academic Year: 2017/8
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 6      [equivalent to 12 CATS credits]
Further information on notional study hours Notional Study Hours: 120
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period:
Modular (no specific semester)
Further information on unit assessment Assessment Summary: CW 100%
Further information on unit assessment Assessment Detail:
  • Assessment Group A: Medicines Optimisation Tool (ass grp A) (CW 40%)
  • Assessment Group A: Case Based Discussion (ass grp A) (CW 20%)
  • Assessment Group A: CARE Tool (ass grp A) (CW 10%)
  • Assessment Group A: Drug Spend Review (ass grp A) (CW 30%)
  • Assessment Group B: Medicines Optimisation Tool (ass grp B) (CW 40%)
  • Assessment Group B: Case Based Discussion (ass grp B) (CW 20%)
  • Assessment Group B: CARE Tool (ass grp B) (CW 10%)
  • Assessment Group B: Guideline Review (ass grp B) (CW 30%)
  • Assessment Group C: Medicines Optimisation Tool (ass grp C) (CW 40%)
  • Assessment Group C: Case Based Discussion (ass grp C) (CW 20%)
  • Assessment Group C: CARE Tool (ass grp C) (CW 10%)
  • Assessment Group C: TCR / Formulary Application (CW 30%)
Further information on supplementary assessment Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites: In taking this module you cannot take PA50338
You must not cover Osteoporosis as a therapeutic area on this unit if you have already used this area in assessments in PA50352/PA50341 (Providing Better Care for the Older Person).
Further information on descriptions Description: Aims:
To update pharmacists on the disease and patient monitoring factors that should be considered when providing pharmaceutical care for patients with conditions of the endocrine system.

Learning Outcomes:
On successful completion of this unit the student will be able to:
1. Describe and analyse the role of the healthcare professional / pharmacist in prescribing, administration and monitoring of medication for patients with diseases of the endocrine system (knowledge and understanding).
2. Explain the disease and patient monitoring factors in this therapeutic area (knowledge and understanding, professional practical skill).
3. Critically evaluate the evidence base for the management of endocrine disease (intellectual skill).
4. Reflect on their own practice in supporting patients with this disease and identify areas for continuous improvement (personal transferable skill).
5. Apply the knowledge gained in this unit to design enhancements to patient facing services and the patient experience (professional practical skill; intellectual skill; knowledge and understanding).

Skills:

* Planning & organisation (Taught/Facilitated)
* Study skills (Taught/Facilitated)
* Handling information (Taught/Facilitated)
* Written communication (Taught/Facilitated/Assessed)
* Working with others (Taught/Facilitated)
* Scientific & practical skills (Taught/Facilitated/Assessed)
* Improving learning & performance (Taught/Facilitated)
* Information & communication technology (ICT) (Taught/Facilitated)
* Problem solving (Taught/Facilitated).

Content:

* Unit Introduction
* Hormonal Contraception and Fertility
* Hormone Replacement Therapy
* Diabetes - Type 1
* Diabetes - Type 2
* Diabetes - Complications
* Thyroid Conditions
* Pituitary Disorders
* Osteoporosis.
Further information on programme availabilityProgramme availability:

PA50201 is Optional on the following programmes:

Department of Pharmacy & Pharmacology

Notes: